How Big is the Leukapheresis Market | Growth & Share 2031

What is the size of Leukapheresis Market?

The growth of Leukapheresis Market is driven by increasing prevalence of leukaemia and other blood disorders, the growing adoption of cell-based therapies, and the rising number of clinical trials for immunotherapy and CAR-T cell development.

Key Growth Drivers of the Leukapheresis Market

• Increasing investments in cell therapy research and personalized medicine
• Rising incidence of hematologic cancers and autoimmune disorders
• Advancements in apheresis technology with improved efficiency and patient safety
• Growing use of leukapheresis in academic and research institutions for cell isolation
• Favourable government funding and regulatory support for cell-based treatment innovations

Leukapheresis Market Trends

Leukapheresis market is moving forward with robust trends such as expanding of immuno-oncology, with rising demand for leukocyte collection in CAR-T therapies and stem cell transplantation. Excluding these, automated leukapheresis systems are gaining preference in hospitals and biopharma labs for consistency and scalability. Moreover, the contract research and manufacturing services are becoming integral in supporting biotech trials. Collectively, all these trends are reshaping the dynamics of the market.

Emerging Developments in the Leukapheresis Market

Leukapheresis market is experiencing numbers of developments especially in next-generation leukapheresis devices with enhanced portability and minimal cell damage. Other developments such as biopharma companies are collaborating with research centres for large-volume leukocyte collections. This market is integrated with AI and data analytics in monitoring apheresis procedures is being explored. Also, the growing emphasis is placed on donor registry expansion and quality control protocols in clinical settings.

List of Leading Companies in the Leukapheresis Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Terumo BCT, Inc.

This company offers advanced leukapheresis systems used globally in therapeutic and research applications with integrated data management.

2. Haemonetics Corporation

This company manufactures automated blood processing and apheresis devices widely used in hospitals and transfusion centres.

3. Fresenius Kabi AG

This company delivers leukapheresis solutions for therapeutic and collection purposes, supporting clinical trials and cell therapies.

4. Asahi Kasei Medical Co., Ltd.

This company provides leukocyte reduction and apheresis systems for clinical and research use, focusing on filtration technology.

5. Macopharma SA

This company develops blood and cell therapy collection kits and leukapheresis disposables used in regulated healthcare environments.

6. Miltenyi Biotec B.V. & Co. KG

This company offers products for cell separation and leukapheresis as part of its portfolio for cell and gene therapy manufacturing.

7. STEMCELL Technologies Inc.

This company provides leukapheresis-derived cells and reagents for research and clinical development in immunology and oncology.

8. Charles River Laboratories International, Inc.

This company offers leukopaks and leukapheresis services for biotech and pharma companies focused on advanced therapies.

How Big is the Leukapheresis Market : FAQs